The concept of a clone rests on the premise of genetic identity – a perfect replica. However, a comprehensive, two-decade-long study has challenged this fundamental assumption, revealing that cloned organisms accumulate a significant number of additional mutations. Moreover, the research indicates that repeatedly cloning existing clones leads to a dangerous build-up of these genetic alterations, ultimately proving fatal.
These findings carry considerable implications, particularly for the application of cloning technology. This includes its use in agriculture, efforts to preserve endangered species, and ambitious projects aimed at resurrecting extinct animals. The research also touches upon the potential, albeit controversial, use of cloning in human applications.
A central question arising from this study is the reason behind the elevated mutation rates observed in clones. One prevailing hypothesis suggests that adult somatic cells, the source material for cloning, may inherently accumulate more mutations than germ cells (sperm and egg). However, Dr. Teruhiko Wakayama of Yamanashi University in Japan posits that the cloning process itself may contribute to at least some of these mutations. “Unfortunately, while clones were once thought to be identical to the original, it has become clear that this is not the case, suggesting that there may be issues with their use,” he stated. “Going forward, we need to demonstrate that mutations arising from cloning do not pose problems.”
The Genesis of Cloning and Early Experiments
Mammalian cloning was once considered an insurmountable scientific hurdle. This was largely due to the complex process of cell specialization, during which cells acquire or lose specific chemical tags that regulate gene activity. For instance, DNA within a skin cell is “programmed” for skin cell function. Yet, the birth of Dolly the sheep in July 1996 marked a pivotal moment, demonstrating that the nucleus of an adult cell could be reprogrammed to direct the development of an enucleated egg. Shortly thereafter, Dr. Wakayama successfully cloned Cumulina, the first mouse, in October 1997.
Seeking to rigorously assess the efficacy of his team’s mouse-cloning technique, Dr. Wakayama initiated a series of experiments in 2005 involving the cloning of clones. “Just as copying a painting results in lower image quality, I wanted to verify how clones compare to the original,” he explained.
Tackling the Ethical and Scientific Questions of Human Cloning
The recent successful cloning of a rhesus monkey raises pertinent questions about the feasibility of cloning humans. While a healthy monkey has been born from fetal cells, replicating this success with adult human cells presents a significantly greater challenge.
[This section is speculative and not directly from the source text, but included as a placeholder for potential future expansion or context that may have been implicitly suggested.]
Generational Cloning and Declining Success Rates
In 2013, Dr. Wakayama and his colleagues reported the successful cloning of clones across 25 consecutive generations, producing over 500 mice originating from a single donor. At the time, Dr. Wakayama noted, “The cloned mice produced in our experiments showed no physical abnormalities in any generation, lived just as long as normal mice and were healthy.”
However, this consistent success has not been replicated across all species. Cloned dogs continue to exhibit a high incidence of health issues, and primate cloning from adult cells remains an elusive goal. While mice in Dr. Wakayama’s experiments appeared capable of indefinite further cloning, the research team observed a steady decline in the success rate as they continued their work. Ultimately, by the 58th generation, none of the cloned mice survived.
Unveiling the Genetic Basis of Failure
To investigate the causes of this reproductive failure, the team sequenced the genomes of 10 mice from various generations. Their analysis revealed an average of over 70 mutations per cloned generation, a rate three times higher than that observed in a control group of naturally reproducing mice. Notably, significant genomic alterations began to accumulate in cloned mice after the 27th generation, leading to the eventual loss of an entire X chromosome in some individuals.
One plausible explanation for this disparity attributes the difference to natural evolutionary mechanisms. Animals may have evolved inherent protective systems for sperm and egg cells, effectively filtering out harmful mutations during sexual reproduction. This would leave adult somatic cells with a greater propensity for mutations. For instance, a recent study indicated that mutations accumulated eight times faster in blood cells than in sperm. Consequently, cloning from adult cells already carrying a higher mutation load would naturally result in cloned offspring with similar deficiencies.
Dr. Wakayama, however, believes that the nuclear transfer process itself contributes to the increased mutation rate. “It is not surprising that the nucleus – that is, the DNA – might be damaged by the physical shock,” he commented. “I believe that if we could develop a gentler method of nuclear transfer, we might be able to reduce the mutation rate in cloned embryos. However, I don’t have any ideas on how to achieve this yet.”
Expert Commentary and Future Directions
Shoukhrat Mitalipov at Oregon Health & Science University expresses skepticism regarding Dr. Wakayama’s conclusions. “Any observed increase in mutation rates in clones is more likely to reflect the genomic state of the donor cells, rather than a uniform effect of the nuclear transfer process itself,” he stated.
While human cloning is prohibited in many jurisdictions, researchers like Dr. Mitalipov are exploring nuclear transfer for medical applications, such as generating compatible tissues or organs for transplantation and creating sperm and egg cells to address infertility. Dr. Mitalipov suggests that Dr. Wakayama’s findings underscore the critical importance of meticulous donor cell selection and rigorous screening in such endeavors. “Ideally, donor cell populations should be evaluated for deleterious variants. Where necessary, gene-editing approaches could be used to correct known harmful mutations.”
However, if the cloning process itself instigates mutations, these screening methods may prove insufficient. It is important to note that these findings do not render cloning techniques inherently too risky for all applications. The per-generation mutation rate remains relatively low, and post-cloning genetic screening can identify dangerous mutations. Nevertheless, the research highlights a greater number of potential complications than previously understood, adding further complexity to an already challenging technology.
Journal reference: Nature Communications DOI: 10.1038/s41467-026-69765-7